Roth Positive on TG Therapeutics (TGTX) Following Q3 Results; Expects Strong ASH Showing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to Roth Positive on TG Therapeutics (TGTX) Following Q3 Results; Expects Strong ASH Showing

TG Therapeutics (TGTX) Misses Q3 EPS by 19c

November 10, 2014 4:21 PM EST

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.51), $0.19 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More